share_log

Lineage Cell Therapeutics's Earnings Outlook

Benzinga ·  Nov 14, 2024 01:03

Lineage Cell Therapeutics (AMEX:LCTX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Lineage Cell Therapeutics will report anearnings per share(EPS) of $-0.04.

Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Past Earnings Performance

The company's EPS beat by $0.01 in the last quarter, leading to a...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment